E-mail this image
FDA approves reverse-anticoagulant drug Kcentra
When patients medicated for atrial fibrillation are brought to emergency departments with severe bleeding, reversing the effects of the anticoagulants they take can be difficult. The FDA has just approved a new product, Kcentra, for this purpose in some patients.
November 9, 2010